Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Lacrimal Duct Obstruction | 2 | 2018 | 15 | 1.41 | Why? |
| Eye Infections, Bacterial | 2 | 2018 | 86 | 1.27 | Why? |
| Blepharoplasty | 2 | 2020 | 39 | 0.87 | Why? |
| Orbital Diseases | 2 | 2021 | 339 | 0.81 | Why? |
| Orbital Neoplasms | 2 | 2017 | 27 | 0.79 | Why? |
| Palate, Hard | 1 | 2018 | 11 | 0.77 | Why? |
| Sweat Glands | 1 | 2018 | 16 | 0.77 | Why? |
| Skull Neoplasms | 1 | 2018 | 7 | 0.77 | Why? |
| Carcinoma, Adenoid Cystic | 1 | 2018 | 11 | 0.77 | Why? |
| Eyelid Neoplasms | 1 | 2018 | 7 | 0.76 | Why? |
| Echo-Planar Imaging | 1 | 2018 | 27 | 0.76 | Why? |
| Canaliculitis | 1 | 2018 | 1 | 0.76 | Why? |
| Sweat Gland Neoplasms | 1 | 2018 | 11 | 0.75 | Why? |
| Actinomyces | 1 | 2018 | 14 | 0.75 | Why? |
| Ophthalmologic Surgical Procedures | 2 | 2020 | 211 | 0.75 | Why? |
| Fibroma | 1 | 2018 | 17 | 0.74 | Why? |
| Optic Nerve Neoplasms | 1 | 2017 | 2 | 0.74 | Why? |
| Actinomycosis | 1 | 2018 | 17 | 0.73 | Why? |
| Eyelids | 1 | 2018 | 40 | 0.73 | Why? |
| Corneal Stroma | 1 | 2018 | 26 | 0.73 | Why? |
| Abducens Nerve Diseases | 1 | 2018 | 38 | 0.72 | Why? |
| Meningeal Carcinomatosis | 1 | 2017 | 15 | 0.72 | Why? |
| Eye Infections, Fungal | 1 | 2021 | 252 | 0.71 | Why? |
| Mucins | 1 | 2018 | 147 | 0.69 | Why? |
| Ophthalmologists | 3 | 2020 | 401 | 0.68 | Why? |
| Lacrimal Apparatus | 1 | 2016 | 17 | 0.68 | Why? |
| Mitomycin | 1 | 2016 | 27 | 0.67 | Why? |
| Sialadenitis | 1 | 2017 | 31 | 0.67 | Why? |
| Dacryocystorhinostomy | 1 | 2016 | 13 | 0.67 | Why? |
| Optic Nerve | 1 | 2017 | 123 | 0.65 | Why? |
| Salmonella typhi | 1 | 2017 | 98 | 0.64 | Why? |
| Ethics, Professional | 1 | 2016 | 21 | 0.63 | Why? |
| Conjunctival Neoplasms | 1 | 2015 | 17 | 0.63 | Why? |
| Carcinoma, Ductal, Breast | 1 | 2017 | 149 | 0.62 | Why? |
| Endophthalmitis | 1 | 2017 | 105 | 0.60 | Why? |
| Corneal Diseases | 1 | 2018 | 172 | 0.60 | Why? |
| Typhoid Fever | 1 | 2017 | 139 | 0.59 | Why? |
| Photography | 1 | 2018 | 255 | 0.59 | Why? |
| Mucormycosis | 2 | 2021 | 832 | 0.57 | Why? |
| Sexism | 1 | 2017 | 278 | 0.49 | Why? |
| Authorship | 1 | 2016 | 240 | 0.49 | Why? |
| Job Satisfaction | 1 | 2017 | 647 | 0.44 | Why? |
| Adenocarcinoma | 1 | 2018 | 651 | 0.44 | Why? |
| Access to Information | 1 | 2016 | 483 | 0.43 | Why? |
| Neuroimaging | 1 | 2018 | 1106 | 0.43 | Why? |
| Diagnostic Imaging | 1 | 2018 | 1044 | 0.39 | Why? |
| Stents | 1 | 2016 | 916 | 0.38 | Why? |
| Patient Care | 1 | 2020 | 1664 | 0.37 | Why? |
| Carcinoma, Squamous Cell | 1 | 2015 | 902 | 0.32 | Why? |
| Smartphone | 1 | 2018 | 1840 | 0.31 | Why? |
| Publishing | 1 | 2016 | 990 | 0.30 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 1573 | 0.29 | Why? |
| India | 9 | 2021 | 11875 | 0.28 | Why? |
| Periodicals as Topic | 1 | 2016 | 1492 | 0.24 | Why? |
| Societies, Medical | 2 | 2020 | 6907 | 0.22 | Why? |
| Eye Injuries, Penetrating | 1 | 2020 | 6 | 0.22 | Why? |
| Eye Foreign Bodies | 1 | 2020 | 7 | 0.22 | Why? |
| Burnout, Professional | 1 | 2017 | 2489 | 0.21 | Why? |
| Biopsy | 3 | 2018 | 2811 | 0.21 | Why? |
| Retinal Artery Occlusion | 1 | 2021 | 57 | 0.21 | Why? |
| Lacrimal Apparatus Diseases | 1 | 2020 | 41 | 0.21 | Why? |
| Nose Diseases | 1 | 2021 | 139 | 0.19 | Why? |
| Breast Neoplasms | 1 | 2017 | 3633 | 0.19 | Why? |
| Retrobulbar Hemorrhage | 1 | 2018 | 1 | 0.19 | Why? |
| Photomicrography | 1 | 2018 | 3 | 0.19 | Why? |
| Patient Acceptance of Health Care | 1 | 2018 | 5002 | 0.19 | Why? |
| Eye Injuries | 1 | 2020 | 128 | 0.18 | Why? |
| Orbital Pseudotumor | 1 | 2017 | 5 | 0.18 | Why? |
| Cefazolin | 1 | 2018 | 31 | 0.18 | Why? |
| Pseudolymphoma | 1 | 2017 | 11 | 0.18 | Why? |
| Chloramphenicol | 1 | 2017 | 10 | 0.18 | Why? |
| Retinal Vessels | 1 | 2021 | 255 | 0.18 | Why? |
| Athletic Injuries | 1 | 2020 | 208 | 0.17 | Why? |
| Fluorescein Angiography | 1 | 2021 | 426 | 0.17 | Why? |
| Amoxicillin-Potassium Clavulanate Combination | 1 | 2017 | 72 | 0.17 | Why? |
| Nasolacrimal Duct | 1 | 2016 | 19 | 0.17 | Why? |
| Therapeutic Irrigation | 1 | 2018 | 167 | 0.16 | Why? |
| Orbit Evisceration | 1 | 2015 | 3 | 0.16 | Why? |
| beta-Lactamase Inhibitors | 1 | 2017 | 104 | 0.16 | Why? |
| Surveys and Questionnaires | 4 | 2020 | 43792 | 0.16 | Why? |
| Antibiotics, Antineoplastic | 1 | 2016 | 128 | 0.15 | Why? |
| Ophthalmology | 2 | 2020 | 1840 | 0.15 | Why? |
| Anesthesia, Local | 1 | 2017 | 163 | 0.14 | Why? |
| Fluorouracil | 1 | 2015 | 169 | 0.14 | Why? |
| Conscious Sedation | 1 | 2017 | 222 | 0.14 | Why? |
| Hypothermia, Induced | 1 | 2017 | 176 | 0.14 | Why? |
| Visual Acuity | 1 | 2021 | 790 | 0.14 | Why? |
| Cisplatin | 1 | 2015 | 209 | 0.14 | Why? |
| Neoplasm Metastasis | 1 | 2017 | 682 | 0.14 | Why? |
| Antifungal Agents | 2 | 2021 | 1828 | 0.13 | Why? |
| Tomography, Optical Coherence | 1 | 2021 | 1008 | 0.13 | Why? |
| Neoplasm Invasiveness | 1 | 2015 | 582 | 0.13 | Why? |
| Confidentiality | 1 | 2018 | 581 | 0.12 | Why? |
| Neoadjuvant Therapy | 1 | 2015 | 554 | 0.12 | Why? |
| Lymphoma | 1 | 2017 | 522 | 0.12 | Why? |
| Ethics, Medical | 1 | 2018 | 533 | 0.11 | Why? |
| Patient Preference | 1 | 2018 | 750 | 0.11 | Why? |
| Immunohistochemistry | 1 | 2018 | 2275 | 0.11 | Why? |
| Male | 14 | 2021 | 367725 | 0.10 | Why? |
| Humans | 23 | 2021 | 930598 | 0.10 | Why? |
| Administration, Oral | 1 | 2017 | 2340 | 0.10 | Why? |
| Biomarkers, Tumor | 1 | 2018 | 1314 | 0.10 | Why? |
| Middle Aged | 10 | 2020 | 270681 | 0.09 | Why? |
| Adult | 10 | 2021 | 244371 | 0.09 | Why? |
| Tomography, X-Ray Computed | 4 | 2018 | 25144 | 0.08 | Why? |
| Endoscopy, Gastrointestinal | 1 | 2018 | 1545 | 0.08 | Why? |
| Diagnosis, Differential | 2 | 2018 | 7220 | 0.08 | Why? |
| Surgeons | 1 | 2020 | 2233 | 0.08 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.08 | Why? |
| Endoscopy | 1 | 2016 | 1564 | 0.07 | Why? |
| Anti-Bacterial Agents | 2 | 2018 | 10083 | 0.07 | Why? |
| Consensus | 1 | 2020 | 6345 | 0.07 | Why? |
| Magnetic Resonance Imaging | 2 | 2021 | 6551 | 0.07 | Why? |
| Quarantine | 2 | 2020 | 18418 | 0.06 | Why? |
| Pandemics | 6 | 2020 | 389249 | 0.06 | Why? |
| Female | 9 | 2020 | 380317 | 0.06 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.06 | Why? |
| Practice Patterns, Physicians' | 1 | 2020 | 4927 | 0.06 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.06 | Why? |
| Ultrasonography | 1 | 2017 | 4409 | 0.05 | Why? |
| Fundus Oculi | 1 | 2021 | 237 | 0.05 | Why? |
| Internship and Residency | 1 | 2020 | 4987 | 0.05 | Why? |
| Retrospective Studies | 3 | 2021 | 105322 | 0.05 | Why? |
| Gastritis | 1 | 2018 | 66 | 0.05 | Why? |
| Wounds, Nonpenetrating | 1 | 2020 | 157 | 0.04 | Why? |
| Anti-Inflammatory Agents | 1 | 2017 | 6153 | 0.04 | Why? |
| Aged | 4 | 2018 | 215776 | 0.04 | Why? |
| Infant | 1 | 2018 | 30274 | 0.04 | Why? |
| Emergency Treatment | 1 | 2020 | 719 | 0.03 | Why? |
| Plasma Cells | 1 | 2017 | 464 | 0.03 | Why? |
| Cross-Sectional Studies | 2 | 2018 | 53120 | 0.03 | Why? |
| Immunoglobulin G | 1 | 2017 | 21571 | 0.03 | Why? |
| Radiotherapy | 1 | 2017 | 608 | 0.03 | Why? |
| Young Adult | 2 | 2020 | 93724 | 0.03 | Why? |
| Surgery, Plastic | 1 | 2020 | 761 | 0.03 | Why? |
| Treatment Outcome | 1 | 2016 | 51732 | 0.02 | Why? |
| Aged, 80 and over | 2 | 2017 | 88759 | 0.02 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.02 | Why? |
| Health Surveys | 1 | 2020 | 2841 | 0.02 | Why? |
| Respiratory Protective Devices | 1 | 2020 | 1637 | 0.02 | Why? |
| Glucocorticoids | 1 | 2017 | 4431 | 0.01 | Why? |
| Antineoplastic Agents | 1 | 2017 | 3550 | 0.01 | Why? |
| Contact Tracing | 1 | 2020 | 8448 | 0.01 | Why? |
| Child | 2 | 2020 | 70012 | 0.01 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.01 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Prevalence | 1 | 2017 | 25773 | 0.01 | Why? |
| Adolescent | 1 | 2017 | 86841 | 0.01 | Why? |
Nair's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(150)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(63)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_